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Abstract
Background: The current surgical therapy of midfacial fractures involves internal fixation in which bone
fragments are fixed in their anatomical positions with osteosynthesis plates and corresponding screws until
bone healing is complete. This often causes new fractures to fragile bones while drilling pilot holes or trying
to insert screws. The adhesive fixation of osteosynthesis plates using PMMA bone cement could offer a
viable alternative for fixing the plates without screws. In order to achieve the adhesive bonding of bone
cement to cortical bone in the viscerocranium, an amphiphilic bone bonding agent was created, analogous
to the dentin bonding agents currently on the market.
Methods: The adhesive bonding strengths were measured using tension tests. For this, metal plates with
2.0 mm diameter screw holes were cemented with PMMA bone cement to cortical bovine bone samples
from the femur diaphysis. The bone was conditioned with an amphiphilic bone bonding agent prior to
cementing. The samples were stored for 1 to 42 days at 37 degrees C, either moist or completely
submerged in an isotonic NaCl-solution, and then subjected to the tension tests.
Results: Without the bone bonding agent, the bonding strength was close to zero (0.2 MPa). Primary
stability with bone bonding agent is considered to be at ca. 8 MPa. Moist storage over 42 days resulted in
decreased adhesion forces of ca. 6 MPa. Wet storage resulted in relatively constant bonding strengths of
ca. 8 MPa.
Conclusion: A new amphiphilic bone bonding agent was developed, which builds an optimizied interlayer
between the hydrophilic bone surface and the hydrophobic PMMA bone cement and thus leads to adhesive
bonding between them. Our in vitro investigations demonstrated the adhesive bonding of PMMA bone
cement to cortical bone, which was also stable against hydrolysis. The newly developed adhesive fixing
technique could be applied clinically when the fixation of osteosynthesis plates with screws is impossible.
With the detected adhesion forces of ca. 6 to 8 MPa, it is assumed that the adhesive fixation system is able
to secure bone fragments from the non-load bearing midfacial regions in their orthotopic positions until
fracture consolidation is complete.
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Background
Internal fixation of osteosynthesis plates in midfacial 
surgery
The objectives for the treatment of facial skeleton fractures
are, besides restoring proper occlusion and the integrity of
the nose and orbitae, the three dimensional reconstruc-
tion of the height, width, depth, and prominence of the
midface [1,2]. These therapy objectives can only be real-
ized by means of adequate immobilisation, using mini
and/or microosteosynthesis plates and screws. This
involves the repositioning of individual bone fragments
to their accurate anatomical positions, and fixation with
osteosynthesis plates. Therewith the use of rigid fixation
devices has revolutionised the treatment of maxillofacial
osteotomies and fractures [3].
Standard systems with screws
The conventional fixation of osteosynthesis plates, made
of titanium or an alloy of it, is carried out by either fasten-
ing screws into pilot holes in the osseous lamella, or
inserting self-tapping screws. Figure 1 features the fixation
technique with screws on a square-cut shaped rabbit bone
fragment of ca. 1 cm2. This procedure requires areas of suf-
ficient cortical bone mass. Otherwise, the presently pro-
posed adhesive reposition method may be difficult to
apply especially at sites where the boney structures are
thin [3]. However, the non-load bearing areas of the
nasoethmoidal, infraorbital, and frontal regions are
extremely thin [2], such that only unfavourable options
for fixation exist in those areas. Thus, the problems are
still encountered in the clinical application of the plates
[3]. The drilling of pilot holes, or fixation of screws in
regions of thin cortical bone can cause further fractures,
due to the force applied to the fragments [4-7], or, more-
over, anatomical structures such as nerves, vessels or the
roots of teeth can be injured when inserting screws [4,6].
In such cases, the conventional fixation of osteosynthesis
plates by means of screw connection is not possible. The
bone fragments cannot, then, be fixed in their orthotopic
positions, and are left to heal indiscriminately. A prereq-
uisite for the unhindered healing of bone following frac-
ture, however, is the immobilization of the fragments
sufficiently long for the osseous closure of the fracture gap
[8-10]. Thus, the method of microplate screw fixation has
different flaws, which affect the therapeutic effect and
functional restoration of the patient [11]. This was the
motive to develop an alternative fixation technique for
mini- and microosteosynthesis plates in the craniofacial
region [1].
Alternative fixation by gluing
Glues have been around for a long time; 4,000 years ago
in Egypt attempts were already made to take care of
wounds by adhesive materials [11,12]. Objects joined by
glues adhere as a result of two different physical forces:
adhesion and cohesion [12]. The glue holds to the object
by adhesion between the two dissimilar materials by
intermolecular forces [12]. Nowadays adhesives are in use
in all types of manufacture. Human structures can be
repaired by adhesives including the fixation of osteochon-
dral fragments, tendon and ligament ruptures and hae-
mostasis as well as middle ear, facial laryngeal or tracheal
surgery. All are challenges for the modern, active surgeon
[11].
One promising alternative seems to be the use of adhesive
systems for internal fixation that were already described in
numerous in vitro and in vivo studies [1,3,13-16]. Accord-
ing to this studies it could be concluded that adhesive sys-
tems might be a useful alternative in bone bonding [3].
Thus, gluing is an attractive technique to fix bone frag-
ments in orthopaedic and trauma surgery providing sev-
eral advantages compared to nailing or screwing
[1,16,17]. Therefore several preconditions have to be met
by a bone adhesive for its all day clinical use. It must have
appropriate adhesive properties, an adequate time of
action and good short- and longterm biocompatibility
without interference with the physiological fracture heal-
ing process [11,17].
Many efforts have been undertaken in the past to generate
substances with adhesive properties for bone gluing pur-
poses. Cyanoacrylates exhibited bad biocompatibility and
high infection rates [17], whereas methacrylates and
fibrin systems lacked sufficient adhesive stability [17,18].
Therefore, all these substances could not be established
Conventional fixation of an osteosynthesis plate with screws Figure 1
Conventional fixation of an osteosynthesis plate with 
screws. The conventional fixation of an osteosynthesis plate 
on a rabbit bone sample with a square cut damage of ca. 1 
cm2 as it is common in midfacial surgery. The plate is fixed to 
the bone by fastening screws in the osseous lamella to both 
the bone of sufficient cortical bone mass and to the fragile 
bone fragment.BioMedical Engineering OnLine 2008, 7:16 http://www.biomedical-engineering-online.com/content/7/1/16
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for all day clinical use [12,17-19]. Established adhesives,
e.g. fibrin and protein-aldehyde systems, are indicated for
soft tissue gluing but not for bone [17]. Fibrin sealant or
fibrin glue (FG) as it is popularly known, has been used in
a number of orthopaedic procedures to enhance osteo-
genesis in human maxillary and mandibular bone, in the
fixation of osteochondral fractures, in spinal surgery and
fixation of osteochondral fragments and bone chips [20].
Furthermore, this biological adhesive, a derivative of
blood is widely used in surgery for their adhesive proper-
ties, hemostatic activity and wound healing process [20].
However their role in bone fracture healing or bone tissue
response is not fully understood and controversies do
exist, despite the fact that this biologic glue can be an
interesting effective osteoinductive substitute [20]. Heiss
et.al. described a newly developed alkylene bis(dilactoyl)-
methacrylate as bone adhesive with some relationship to
polymethylmethacrylate (PMMA) which has been used
extensively in dentistry [18], and in orthopaedic surgery
for anchoring of prostheses [17]. Preliminary in vitro data
of this adhesive showed good biocompatibility in vivo
without impairment of physiological fracture healing. It
also shows good biodegradability characteristics [17]
which are, however, not required in our study. By con-
trast, Grossterlinden et.al. observed an extensive tissue
destruction after 6 months in all animals of a polymer
group when alkylene bis(dilactoyl)-methacrylate was
used for screw augmentation and for covering the osteot-
omy surface before osteosynthesis to analyze the influ-
ence of the material on bone healing [19]. This was
attributed to a massive foreign body reaction at the histo-
logical level [19].
Nevertheless a longstanding history of research in this
field a clinically applicable alternative was not found
within the field of bone gluing. Former applications
failed, because these adhesives were not tailored to the
conditions met within the living organism [12]. However,
the importance of this issue will persist into be more in
the future and more studies about biocompatibility and
bond strength of new bone adhesives will follow [12].
Fixation with PMMA-Cement
In this article, we present an alternative technique using
bone cement to affix thin cortical bone fragments to oste-
osynthesis plates in the surgical therapy of midfacial frac-
tures. This procedure involves the conventional screw
connection of the plate to thick cortical bone structures,
while interjacent or delicate bone fragments are adhe-
sively fastened to the plate with bone cement applied
through the screw holes in the plate. Figure 2 represents
this adhesive fixation technique also with a square-cut
shaped bone fragment of ca. 1 cm2. The bone cement
based on PMMA currently used with orthopaedic
implants, for example for a hip or knee implant, is suita-
ble for this application.
When implementing the adhesive fixation of osteosynthe-
sis plates in midfacial surgery with a PMMA bone cement,
one must be aware that the bonding mechanism that
takes place differs from that when cementing a hip or knee
endoprosthesis during orthopaedic surgery [1].
PMMA-Cement in orthopaedics
Polymethylmethacrylate (PMMA) has been widely used
in dentistry since 1930s, and in orthopaedic surgery, for
the sealing of prostheses. It is not a true adhesive but inter-
locks well with cancellous bone. Charnley and Kettlewell
pioneered the use of PMMA as a grouting agent in total
hip replacement [21]. Up to now, there has been a con-
stant increase in the use of that cementing system for
implant anchorage, which shows the significance of this
cementing technique. According to the Swedish Total Hip
Replacement Register, the vast majority (93%) of primary
total hip replacements (THRs) were performed using
PMMA cement in the year 2000 [22].
In order to generate sufficient fixation between the bone
and PMMA bone cement when cementing, for example, a
THR on a sclerotic acetabulum bone structure, which is
dense and plane, the sclerotic bone is cleared away until
the subjacent spongious structure is exposed. Spongious
Partially adhesive fixation of an osteosynthesis plate Figure 2
Partially adhesive fixation of an osteosynthesis plate. 
The new technique for the adhesive fixation of an osteosyn-
thesis plate. The osteosynthesis plate is fixed on a rabbit 
bone sample with a square-cut damage of ca. 1 cm2. On suffi-
cient cortical bone mass structures the plate is fixed with 
screws as usual. On the fragile bone fragment the plate is 
adhesively fixed to the bone of the sqare-cut damage with a 
PMMA bone cement and with an amphiphilic bone bonding 
agent as an intermediate layer.BioMedical Engineering OnLine 2008, 7:16 http://www.biomedical-engineering-online.com/content/7/1/16
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bone has a structured porous surface area. When cement-
ing the ductile bone cement is pressed into this porous
bone structure. Thereby, the ductile bone cement fills the
cavities of the porous bone and, after polymerisation, ade-
quate fixation between the bone and bone cement is
achieved, due to the retention forces of the rough surface
[23,24].
PMMA-Cement for adhesive fixation on non-retentive 
surfaces
The surface structure and associated wetting properties of
the compact bones of the midface pose a problem for the
fixation of reconstruction plates using the common
PMMA bone cement. On the one hand, the compact bone
of the midface has a cortical structure and is extremely
dense and plane, lacking the surface cavities of spongious
bone. Thus, the bone structure does not allow for the cre-
ation of the micro and macro retention forces between
cement and bone described above for spongious bone,
and the cement cannot anchor to the bone. On the other
hand, the wetting properties of bone and PMMA bone
cement are different [23,25]. Bone has hydrophilic prop-
erties and for water its wetting angle is, thus, lower than
90°, indicating that bone can be wetted by water very
well. The monomers of PMMA bone cement, by contrast,
have a hydrophobic character and a surface energy lower
than that of bone [25]. Therefore, bone is not wetted by
the monomers of ductile PMMA bone cement. As a result
of the different wetting properties it is impossible to build
adhesion forces between bone and bone cement
[1,16,23,25,26]. Thus, if adhesion between bone and
cement is to be created, the wetting properties of the two
bonding partners must be adapted to each other.
Bone bonding agent
The use of a bone bonding agent that is similar in compo-
sition to the dentin bonding agents having been in clinical
use for years may offer a solution to the problem of
incompatible wetting properties of the bonding partners
[16,23-25,27]. The idea of such a bonding agent was pat-
ent-registered by Marx et al. in the year 2005. The inven-
tion concerns a novel coupling agent which hardens fast
as it is photochemically polymerized for an efficient
adherence between the bone cement and the bone surface
during endoprosthetic implant grafting [27].
The dentin bonding agents are amphiphilic in nature and
therefore able to bond with both hydrophilic dentin and
hydrophobic composits, and according to several studies
the use of dentin adhesives seemed to produce higher
bond strength to bone than that attained with the
cyanoacrylate adhesive [3,13-15]. Furthermore, cyanoacr-
ylates exhibited bad biocompatibility and high infection
rates as mentioned above [17].
Like dentin, bone also has a hydrophilic character, as a
consequence of its high content of organic substances,
especially collagen. In addition bone and dentin also have
analogous chemical compositions [28] whereas the anor-
ganic matrix of bone is ca. 67–70% by weight and that of
dentin ca. 70% by weight, both consisting predominantly
of Hydroxyapatit (Ca2+) [29-31]. The organic matrix of
bone is ca. 22–23% by weight, while that of dentin is ca.
20% by weight, both composed mainly of collagen type I
(NH2); the remaining weight percentage in both dentin
and bone consists of water [29-31]. Furthermore bone
cement, as a resin, is comperable to the composits, also
hydrophobic in nature [23,25]. Thus, the field of dentistry
has faced the same problem associated with a difference in
wetting properties of the various components. This prob-
lem has been resolved with the use of dentin bonding
agents. Consequently, the adhesion between bone and
bone cement may nevertheless be achieved with the help
of an interlayer system that forms a bridge between the
bonding partners, accommodating the wetting properties
of both partners [23,27].
Thus, analogous to the dentin bonding agents, the newly
developed bone bonding agent is amphiphilic in nature.
This amphiphilic bone bonding agent consists mainly of
monomers that possess both hydrophilic and hydropho-
bic properties. The bone bonding agent as it is shown in
Figure 3 (application of the bone bonding agent, yellow
drop) contains hydrophobic monomers like MMA mole-
cules and hydrophilic functional groups like hydroxy
groups R-OH and carboxy groups R-COOH, where R is a
placeholder for the organic rest. After the application of
the bone bonding agent, it will infiltrate the bone surface,
building up a hybrid layer as it is shown in Figure 4. There-
fore the hydrophilic monomers in the bone bonding
agent serve to optimize the wetting of bone having a
hydrophilic character. Than, the functional groups of the
bone bonding agent will build chemical bondings of elec-
trostatic nature to bone. Thereby the hydrophilic carboxy
groups (R-COOH) of the bone bonding agent are able to
build a chemical connection to the calcium ions (Ca2+) of
the anorganic matrix of bone, while the hydrophilic
hydroxy groups (R-OH) build a water-insoluble bond
with the aminogroups (NH2) of the organic matrix of
bone. In addition the bone bonding agent contains pho-
toinitiators for curing with UV light. After curing, the
applied amphiphilic interlayer forms a coating, as shown
in Figure 5, to which bone cement can adhere. In order to
optimize the wetting of bone cement, having a hydropho-
bic character, the bone bonding agent contains hydropho-
bic monomers [16,27].
Modified PMMA-Cement
The standard PMMA bone cements used in orthopaedics
are solely self-curing, meaning that polymerisation takesBioMedical Engineering OnLine 2008, 7:16 http://www.biomedical-engineering-online.com/content/7/1/16
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place as a result of a chemical reaction when powder and
liquid components are combined. This self-curing polym-
erisation process, as used in orthopaedics, takes a total of
10 to 15 minutes, whereby the initial phase, during prep-
aration and implantation of the prosthesis, proceeds
slowly and the final phase, following implantation, is
more rapid. For cementing osteosynthesis plates in midfa-
cial surgery, however, it is more desirable to have control
over the initiation and duration of polymerisation. In
contrast to the implantation of orthopaedic prostheses,
the length of surgical fixation procedures using osteosyn-
thesis plates is variable according to the number of plates
required, and the length of time necessary to apply the
cement through the screw holes of the plates.
In order to lengthen the processing time, standard PMMA
bone cement was modified with an inhibitor to delay the
chemical reaction time and, thus, the polymerisation. In
order to allow for the initiation of polymerisation to be
determined individually through the use of UV light, as it
is desired in the fixation of osteosynthesis plates, standard
PMMA bone cement was modified with a photoinitiator.
Methods
In-vitro experiments were carried out using bovine bone
samples from the femoral diaphysis. The bones were
sawed into slices and the bone marrow was removed. Dur-
ing preparation, the fresh bone was kept moist with 0.9
weight-% NaCl-solution and was deep frozen for storage.
Metal plates of titanium alloy TiAl6V4 were designed with
a size of 30 × 5 × 1 mm, similar to the osteosynthesis
plates used in surgery. The screw holes had a diameter of
2 mm, and were spaced at a distance of 10 mm. The bone
bonding agent was prepared, as above-mentioned, using
amphiphilic monomers and photoinitiators.
Application of the bone bonding agent to bone Figure 3
Application of the bone bonding agent to bone. Appli-
cation of the amphiphilic bone bonding agent to the 
hydrophilic bone. The bone bonding agent (yellow drop) 
contains hydrophobic monomers like MMA molecules 
(marked with the black triangles) and functional groups like 
hydroxy groups R-OH and carboxy groups R-COOH, where 
R is a placeholder for the organic moiety. The bone (grey 
marked area at the bottom of the diagramm) contains cal-
cium ions Ca 2+ within its anorganic matrix and amino groups 
R-NH2 within its organic matrix; R is a placeholder for the 
organic moiety.
Chemical bonding of the bone bonding agent to the bone Figure 4
Chemical bonding of the bone bonding agent to the 
bone. With the infiltration of the applied amphiphilic bone 
bonding agent (yellow marked area) into the bone surface 
(grey marked area at the bottom of the diagram) a hybrid 
layer will be built. Therefore the hydrophilic monomers in 
the bone bonding agent serve to optimize the wetting of 
bone, which likewise has a hydrophilic character. Than, the 
functional groups of the bone bonding agent will build chemi-
cal bondings of electrostatic nature to bone. Thereby the 
hydrophilic carboxy groups (R-COOH) of the bone bonding 
agent are able to build a chemical connection to the calciumi-
ons (Ca2+) of the anorganic matrix of bone, while the 
hydrophilic hydroxy groups (R-OH) build a water-insoluble 
bond with the aminogroups (NH2) of the organic matrix of 
bone.BioMedical Engineering OnLine 2008, 7:16 http://www.biomedical-engineering-online.com/content/7/1/16
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Before cementing the metal plates to the bone, the periost
was removed using a raspatory. The bone bonding agent
was then applied with sterile cotton wool and spread onto
the bone surface, and the polymerisation of the bone
bonding agent was induced with UV light. The metal
plates were then affixed to the bone samples using bone
cement, punctiformally applied through the screw holes.
Subsequently, the bone cement was cured using UV light
and the samples were stored for 1 to 42 days at 37 degrees
C in two groups of 20 samples, with group A under moist
conditions at 100% humidity, and group B completely
submerged in a 0.9 weight-% NaCl-solution. Tension tests
according to DIN EN ISO 527-1 were carried out at day 1
and day 42. Further samples, prepared according to the
described procedure, were tested directly following
cementation in order to determine the approximate pri-
mary stability of the plates. A reference group consisting of
samples prepared without the bone bonding agent was
also tested directly after cementation.
Strain-extension-diagrams of the results were recorded,
whereby the detected stress σ, a result of the force F relat-
ing to the adhesive cross-section, was graphed in depend-
ence of the strain ε on the sample. The maximum stress,
σmax, corresponds to the ultimate strength σfracture and,
thus, to the adhesive strength of the sample.
Results
Adhesive strengths of cemented plates
Figure 6 features the average adhesive strengths and stand-
ard deviations computed for the samples prepared with
the amphiphilic bone bonding agent (light green column
on the right side) and without it (light green column on
the left side). Figure 6 also shows the effects on the adhe-
sion strength of both moist storage (dark blue columns)
and wet storage (light blue columns) at 37 degrees C
whereas the samples were stored for 1 or 42 days. Adhe-
sion forces which were detected directly after cementation
in order to determine a value for the primary stability of
the adhesively fixed plates were significantly lower for the
plates fixed without the bone bonding agent of ca. 0.2
MPa than those of the samples prepared with the bone
bonding agent of 8.5 ± 1.7 MPa. The adhesion forces for
the reference samples, cemented without conditioning the
bone, were nearly undetectable, indicating that adhesion
did not take place between the cement and the cortical
bone structure. In contrast, the average adhesive strength
of ca. 8 MPa detected here directly after cementation for
the samples conditioned with the bone bonding agent
indicates that the adhesively fixed plates with an adhesive
area of 3.14 mm2 could be loaded with up to 2.7 kg before
breakage occurred. Moist storage over 24 hours resulted in
a decreased adhesive strength of 6.1 ± 3.2 MPa, as com-
pared to 8 MPa primary stability within the reference
group. No significant difference in adhesive strength was
measured for the samples stored for 42 days under moist
conditions with 5.7 ± 1.4 MPa. The samples stored sub-
merged in a 0.9 % weight-NaCl-solution, however,
showed a constant average adhesion strength at both 1
and 42 days of storage of 8.1 ± 4.3 MPa and 7.5 ± 4.5 MPa,
respectively.
Discussion
The newly developed bone bonding agent is advanta-
geous for the clinical application of rigid fixation, in that
it provides an alternative fixation technique when the use
of screws is not possible. With the use of adhesive fixation,
new trauma to delicate bone structures can be avoided
during attachment to an osteosynthesis plate. Most new
traumas result from the force applied when drilling pilot
holes or fastening screws [5-7]. Up to now, the fixation of
small or delicate bone fragments has been largely impos-
sible, often leading to the healing of bone fragments in an
undesirable anatomical situation [8]. With the new bone
bonding agent and light-curing bone cement, the precise
fixation of small and fragile fragments should become
possible. Adhesive fixation with a cementing area of a few
square millimeters affords an adequate supply of the sur-
rounding periost, and undisturbed bone healing. Further,
this adhesive fixation technique does not lead to the dem-
ineralisation of bone, in contrast to the adhesive fixation
of synthetic fillings in conservative dentistry where the
Polymerisation of the bone bonding agent Figure 5
Polymerisation of the bone bonding agent. In addition 
to the chemical connection between the bone bonding agent 
and bone, the MMA molecules are polymerised with the help 
of UV-light building up crosslinks forming a coating to which 
bone cement can adhere.BioMedical Engineering OnLine 2008, 7:16 http://www.biomedical-engineering-online.com/content/7/1/16
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dentin surface is demineralized by the etching method. A
further benefit of this drill-free osteosynthesis fixation sys-
tem is the elimination of the risk of screw breakage or
overwinding.
For regions of bone with a low cortical bone mass, that are
not exposed to significant muscle traction or masticatory
forces, average bond strengths of 6 to 8 MPa show poten-
tial for application in the adhesive fixation system. These
results serve as an indication for further investigation. The
next step should be to validate the results obtained here
from in vitro bovine bone samples with in vivo animal
experiments. For these in vitro tests, bovine bones were
selected due to the fact that the ossification mode of the
membranous bone of the bovine femoral diaphysis is
comparable to the desmal ossification of the human vis-
cerocranium [9]. Subsequently, the applicability of this
newly developed system for use with human cortical bone
should be examined.
Furthermore, the debonding of the plates shall be tested.
In our in-vitro investigations a destructive method was
used to determine the adhesive tensile strength. So, fur-
ther examinations have to be done in order to develop a
suitable method for the debonding of the plates. For
example, one possibility could be to ream the PMMA
cement from the screw holes of the plates.
Aside from the classic midfacial fractures, this technique
could be used where other delicate bone fragments would
previously have been tried to secure using screws, such as
in cases of corrective osteotomy for craniosynostosis, for
fractures of the orbital walls, or anterior walls of the max-
illary and frontal sinuses, for periimplantation defects, or
with the use of distractors.
Bone bonding agent
Many efforts have been undertaken in the past to generate
substances with adhesive properties for bone gluing pur-
poses. Cyanoacrylates exhibited bad biocompatibility and
high infection rates, whereas methacrylates and fibrin sys-
Adhesive bonding strength of cemented osteosynthesis plates Figure 6
Adhesive bonding strength of cemented osteosynthesis plates. Average adhesive bonding strength and standard devi-
ation measured in tension tests. The primary stability of the adhesive fixed plates is determined directly after cementation 
(without storing the samples, 0d). Samples prepared with the amphiphilic bone bonding agent (light green column on the right 
side) and, as a reference, without the bone bonding agent (light green column on the left side). The diagram also shows the 
effects on the adhesion strength of both moist storage (dark blue columns) and wet storage (light blue columns) for 1 and 42 
days at 37 degrees C.BioMedical Engineering OnLine 2008, 7:16 http://www.biomedical-engineering-online.com/content/7/1/16
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tems lacked sufficient adhesive stability [17,18]. A new
class of bone adhesives based on alkylene bis(dilactoyl)-
methacrylates may meet the requirements to bridge the
gap between bench and bedside [17,19], however, the
long-term biocompatibility as well as the combination
with a copolymer that is used for both fragment adaption
and implant fixation has to be investigated [19]. The long-
term results obtained from the study of Grossterlinden
et.al. suggest that (i) short-term observation not always
allow valid conclusions regarding the biocompatibility of
biomaterials, (ii) that biocompatibility might vary
between species, and (iii) that the polymer based on
alkylene bis(dilactoyl)-methacrylate used in this setting,
although previously attributed to be a good candidate for
clinical use in patients, does not meet the necessary crite-
ria and tremendously interferes with the physiology of
skeletal repair [19].
Preliminary data confirmed the adhesive potential of dif-
ferent dentin bonding agents to bone and their efficacy in
bone fixation under in vitro conditions. Maurer et al.
compared tensile bond strength of three dentine adhesive
systems (Excite, Clearfil New Bond, Etch & Prime®3.0)
and two cyanoacrylate adhesives (Cyano Veneer®, His-
toacryl®) to porcine bone in vitro [29,31]. The tensile
bond strengths were measured 15 min after application
and after light curing of the composite material Tetric ®
Ceram (colour A2), without storing the samples [29]. The
measured tensile bond strengths are shown in figure 7;
Clearfil New Bond showed significantly higher bond
Bonding strengths overwiev Figure 7
Bonding strengths overwiev. Average adhesive bonding strengths and standard deviations detected in a study of Maurer et 
al. using different kinds of bonding agents like dentin bonding agents (Excite, Clearfil New Bond, Etch & Prime®3.0) and tissue 
adhesives (Cyano Veneer®, Histoacryl®) [3, 29, 31], compared with the average bonding strength reached with the self-made 
amphiphilic bone bonding agent. The bonding partners variations: porcine bone/Tetric® colour A2, porcine bone/porcine bone 
and bovine bone/PMMA cement. Tensile strength tests were done at day 0 (day of preparing the samples, without storing the 
samples).BioMedical Engineering OnLine 2008, 7:16 http://www.biomedical-engineering-online.com/content/7/1/16
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strength than the other four adhesives. The outcomes of
the authors'study (day 0) are also added in figure 7 wheras
the PMMA cement was equated with the composit. Fur-
ther investigations of Maurer et al. and Bekes et al. com-
pared the tensile bond strengths attained between bone
and bone using two different adhesive systems (Clearfil™
New Bond and Histoacryl®) in vitro on porcine bone sam-
ples. The tensile bond strength was measured 15 min after
application [3,31]. The outcomes are also added in figure
7.
An one-to-one comparison to other studies would not be
feasible since the various study designs of former investi-
gations are largely different. The use of dentin varies from
animal to human, the use of the composits are largely dif-
ferent, e.g. Z 100 composite (3M ESPE), Tetric® colour A2
(Vivadent), Brilliant Dentin A2 (Coltène), also the adhe-
sives differ from each study and the appliance of them. In
addition the adhesion tests are varying from tension tests
to shearbonding tests.
However, the most dentin adhesive systems include the
etching technique. Etching the dentin surface means that
the collagen structure would be exposed by removing the
mineral part of the dentin structure so that the bonding
agent could penetrate into the collagen matrix. The adhe-
sive system presented in this study works without the
etching technique. This should be preferable in order to
preserve the bone structure and moreover for easy han-
dling in surgery.
The bone bonding agent [27], which was primarily devel-
oped for application in orthopaedics [25,32], has been
tested in previous experiments, e.g. in which two cortical
bone samples were connected using PMMA bone cement
[23,25]. In this investigation, sandwich samples (cortical
bone/bone bonding agent/PMMA bone cement/bone
bonding agent/cortical bone) were tested in a three-point
bending test without storage and with long-term storage
of up to 120 days [23,25]. These experiments demon-
strated that the compound stability between bone cement
and cortical bone was 50- to 100-times higher with the use
of the bonding system[25]. While the use of PMMA bone
cement is the standard in orthopaedic procedures, such as
total hip replacement (THP) or total knee arthroplasty
(TKA), the high level of anchorage achieved is due to the
cancellous structure of the spongious bone which is filled
by the cement. However, when an implantation is neces-
sary in an area of dense cortical bone, the bone cement is
then unable to penetrate into the bone structure and
achieve anchorage [23,25]. It is necessary in such cases, to
establish adhesive bonding between bone and PMMA
bone cement, a situation which is normally impossible
due to the difference in wetting properties between the
two partners. The newly developed bone bonding agent,
however, is able to accommodate both wetting properties,
thereby leading to adhesive bonding [25,32,33]. Previous
investigations by Marx et al. let to the development of this
bone bonding agent in order to upgrade the insufficient
anchorage of bone cement to bone due to the fact that the
two main reasons of prosthesis loosening are hydrolysis
and the insufficient anchorage of the PMMA bone cement
to bone, reflected by aseptic prosthesis loosening
[25,27,32-34]. Furthermore bone substance could be pre-
served if it is possible to anchor the implants with the help
of adhesion forces, because there would be no longer the
need of clearing away the quasicortical bonestructure,
which is, especially in the view of revision surgery very
important to be conserved. Therefore in-vitro studies were
designed with the cadavers of sheeps. Plasma activated
acetabulum cups made of polyethylene were implanted
into the acetabular cavity of those cadavers using the cur-
rent cementing technique with and without the newly
developed bone bonding agent [25,33]. The achieved
bonding strengths were determined in torsional-turn out
tests; the compound stability showed in mean a 1.8-fold
increase of the interface strength in case of preconditioned
acetabular cavities with the bonding system [25,33]. In
further investigations animal testings were done on
sheeps with conventional cemented hip arthroplasty
stems with and without conditioning the bone with the
new bone bonding agent [32,34]. In this investigation all
stems of the verum group showed firm bonding of cement
to bone, while in 7 of the 10 controls the stems with
adherent cement could be easily pulled out off the bony
implant bed. When preconditioned with the amphiphilic
bonder, cemented stems showed a markedly higher adhe-
sive strength to the cancellous bone without signs of
inflammation or neoplasia. Thus, the bonder was bio-
compatible. The conclusion of this study: this procedure
might offer enhanced longevity of cemented femoral revi-
sion stems in hip arthroplasty [34]. These in-vivo-experi-
ments also demonstrated that the application of this
newly bone bonding agent in vivo can achieve adhesive
bonding between bone and bone cement. The use of the
bone bonding agent had the effect of no debonding in the
interface bone and PMMA bone cement in every case,
whereas in seven of ten cases debonding comes out when
the bone bonding agent was not applied [32,34].
The bones of the midface are cortical in structure and,
therefore, dense and smooth. The need for an alternative
fixation of osteosynthesis plates in this midfacial region
motivated the application of the developed bone bonding
agent for the adhesive fixation of the plates. Modification
of this agent into a "one bottle" adhesive system would
allow simple application of bone bonding agent in clini-
cal use, and thus the fixation of osteosynthesis plates by
means of bone cement. The present study demonstrated
that the adhesive fixation of osteosynthesis plates byBioMedical Engineering OnLine 2008, 7:16 http://www.biomedical-engineering-online.com/content/7/1/16
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means of bone cement without conditioning the bone
with bone bonding agent does not give rise to adhesion
forces between the PMMA bone cement and cortical bone,
having produced a nearly non-detectable adhesive
strength of ca. 0.2 MPa. However, the in vitro tests involv-
ing the use of bone bonding agent showed an average
adhesive strength of ca. 6 MPa with an adhesive area of
3.14 mm2, confirming the results of previous examina-
tions. The adhesive bonding between bone and a PMMA
bone cement is possible, and can doubtlessly be applied
clinically. The adhesive strength of ca. 8 MPa (primary sta-
bility) allowed for the adhesively fixed plate to be loaded
with ca. 2.7 kg before bond failure was noticable in the
interface between bone cement and bone. The long-term
stability of ca. 7 MPa was demonstrated after 6 weeks of
storage in a 0.9 weight-% NaCl-solution at 37 degrees C.
This translates into the ability of the adhesive bond to
withhold up to 2.3 kg of weight. This is a favorable result,
given the extremely small adhesive area.
The high level of standard deviation computed (20–64 %)
is easily understandable, considering that bone is a bio-
logical material with variations in chemical and biome-
chanical properties among individuals and changing
surface areas. This naturally applies to both human and
animal bone. The bone samples used in this study were
obtained from the same slaughterhouse, but were
obtained on different days, and from different cattle, rep-
resenting a source of error that cannot be controlled when
testing biological materials. The detection of such high
levels of standard deviation is not a new phenomenon,
having been described as early as 1968 by Ansell and
Scales [35]. These investigators determined the need for a
synthetic standard material for their investigations on the
holding force of osteosynthesis screws using rip-off tests.
They succeeded in demonstrating the same rip-off forces
with both bone and the synthetic material, though the lev-
els of standard deviation varied greatly [35]. The use of
phenolic resin as a standard material has been confirmed
and reconfirmed by various authors in the years 1972 and
1980 [36,37]. In 1998, Heidemann conducted a compar-
ative study of the holding force of osteosynthesis screws
using materials such as porcine bone, beech tree wood,
and PVC [38]. This study also demonstrated extremely
high standard deviation levels in the experiments with
porcine bones, while the lowest levels of standard devia-
tion were calculated with PVC. For the study presented
here, however, no standard material could be used, as the
experiments were designed to test the effectiveness of the
bone bonding material, in light of the clinical application
in midfacial surgery. The wetting properties of bone were
an essential factor in this experiment, and could not have
been replicated in a synthetic material.
Modified PMMA-Cement
For the clinical application of adhesively fixing osteosyn-
thesis plates in midfacial surgery, a UV light-curing PMMA
bone cement was developed by adding a photoinitiator to
the PMMA powder component. This modified cement
allows for a surgeon to individually determine the point
in time at which polymerisation begins, in contrast to
standard PMMA bone cements where the polymerisation
takes up to 15 minutes, which would cost the surgeon and
his team precious time when adhesively fixating an osteo-
synthesis plate during midfacial surgery. With the addi-
tion of a photoinitiator to the PMMA bone cement, the
polymerisation time can be reduced from 10–15 minutes
to as low as 90 seconds. This represents a much more
manageable time frame for the fixation of an osteosynthe-
sis plate. The wavelength of UV light used in this experi-
ment was ca. 400–500 nm which was appropriate to the
photoinitiator used in this system. Further experiments
might modify the wavelengths used, and perhaps achieve
even shorter light-curing times.
Conclusion
Contrary to the biologically and technically well-founded
expectations that the adhesive bonding of PMMA cement
to cortical bone is impossible, this in vitro study showed
that this goal can be achieved. The conditioning of
hydrophilic cortical bone with an amphiphilic bone
bonding agent results in high adhesive strength to hydro-
phobic PMMA bone cement. This newly developed bone
bonding agent is similar to the amphiphilic dentin bond-
ing agents, which were made available in recent years. The
amphiphilic dentin bonding agents allow the adhesive
connection of hydrophilic dentin to hydrophobic com-
posits. The reference samples presented in our investiga-
tions confirmed again that the adhesive bonding between
hydrophilic and hydrophobic bonding partners is impos-
sible when an amphiphilic bonding agent is not used.
Conditioning of the bone with the bone bonding agent
leads to the successful adhesive bonding of PMMA cement
to cortical bone. These results lead research into the punc-
tiformally adhesive fixation of osteosynthesis plates to
cortical bone in midfacial surgery.
The new approach for the reconstruction of midfacial frac-
tures presented here through in vitro experiments offers
new possibilities for the fixation of osteosynthesis plate
systems. The decrease in trauma to the bone is a distinct
advantage of this system over the present techniques. This
is especially true for fixation in regions of extremely low
cortical bone mass that offer only limited possibilities for
conventional fixation with screws. It is assumed that the
adhesive fixation system developed here would be able to
secure bone fragments from the non-load bearing midfa-
cial regions in their orthotopic positions until fracture
consolidation is complete. The extent to which the resultsBioMedical Engineering OnLine 2008, 7:16 http://www.biomedical-engineering-online.com/content/7/1/16
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obtained here on bovine bone in vitro can be applied to an
in vivo system will be determined in future animal experi-
ments. Subsequently, the applicability of these results for
human cortical bone should be examined in clinical stud-
ies.
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